TCR-T Cell Therapy on Advanced Solid Tumors

This study is testing a new type of personalized immune cell therapy called TCR-T cell therapy in people with advanced solid tumors (including lung, pancreatic, and colorectal cancers) that have not responded to standard treatments. TCR-T therapy uses your own immune cells that are genetically engineered to recognize specific cancer proteins. **You may be eligible if:** - You are over 18 years old - You have an advanced solid tumor confirmed by biopsy or cytology - Your cancer has stopped responding to standard treatments or no standard treatment exists - Specific tumor types include: non-small cell lung cancer after platinum-based chemotherapy, pancreatic cancer after at least one systemic therapy, colorectal cancer after at least two prior treatment regimens, or other advanced solid tumors **You may NOT be eligible if:** - Your cancer has not yet been tried on standard therapy options - Your overall health or organ function does not meet study requirements Talk to your doctor to see if this trial is right for you.